New Targeted Radiation Treatment Reduces Bone Pain,
Extends Survival in Prostate Cancer Patients
Loyola University Medical Center is among the first hospitals in Chicago to offer a new targeted radiation treatment that can reduce bone pain and the incidence of fractures – and also extend patients’ lives.
The treatment, recently approved by the Food and Drug Administration, is called Xofigo®. A radioactive substance, radium-223, is injected into the patient. Because it is similar to calcium, radium-223 binds to the bone.